PAPPAS CAPITAL
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. They operate three lines of business: Pappas Ventures, their flagship venture arm; Specialized Fund Management, where we create and manage custom-tailored investment vehicles; and Translational Medicine, where we partner with research universities to accelerate the development of their scientific discoveries and inventions.
PAPPAS CAPITAL
Industry:
Biotechnology Delivery Medical Device Pharmaceutical
Founded:
1994-01-01
Status:
Active
Contact:
919-998-3300
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-25 | Aktis Oncology | Pappas Capital investment in Series A - Aktis Oncology | 84 M USD |
| 2022-06-02 | Yueer Gene | Pappas Capital investment in Series B - Yueer Gene | 50 M USD |
| 2022-06-02 | NuProbe | Pappas Capital investment in Series B - NuProbe | 50 M USD |
| 2022-04-14 | Us2.ai | Pappas Capital investment in Series A - Us2.ai | 15 M USD |
| 2022-02-23 | Plexium | Pappas Capital investment in Series B - Plexium | 102 M USD |
| 2022-01-05 | AvengeBio | Pappas Capital investment in Series A - AvengeBio | 45 M USD |
| 2021-09-29 | BioAtla | Pappas Capital investment in Post-IPO Equity - BioAtla | 75 M USD |
| 2020-12-09 | Reneo Pharmaceuticals | Pappas Capital investment in Series B - Reneo Pharmaceuticals | 95 M USD |
| 2020-07-31 | Cyclerion Therapeutics | Pappas Capital investment in Post-IPO Equity - Cyclerion Therapeutics | 24 M USD |
| 2020-07-15 | BioAtla | Pappas Capital investment in Series D - BioAtla | 72.5 M USD |
More informations about "Pappas Capital"
Team - Pappas Capital
Glenda's broad strong organization skills help keep Pappas Capital running smoothly.See details»
Pappas Capital - Crunchbase Investor Profile
Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. They operate three lines of business: Pappas …See details»
Pappas Capital - LinkedIn
Pappas Capital | 2,521 followers on LinkedIn. Founded in 1994, Pappas Capital is a global venture capital and commercial development firm that specializes in investments in next …See details»
Partners - Pappas Capital
Prior to Pappas Capital and Allievex, Tom was the President and CEO of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD), a Pappas Ventures III founded company, which …See details»
William Pay - Pappas Capital | BIO-Europe Spring Speaker
William is a member of the BayHelix Group, a non-profit professional organization of business leaders from the investment and health-tech communities. The group’s mission is to shape the …See details»
Pappas Capital - Investments, Portfolio & Company Exits
Pappas Capital has made 32 investments. Their most recent investment was on Nov 19, 2024, when EarthOptics raisedSee details»
Pappas Capital - Funding, Financials, Valuation & Investors
Pappas Capital has raised a total of $85.8M in a single venture fund, A. M. Pappas Life Science Ventures V. This fund was announced on Jan 15, 2019 and raised a total ofBridging the Early …See details»
Pappas Capital - Investor Profile, Portfolio & Team - Tracxn
Mar 4, 2025 Pappas Capital is a venture capital firm founded in 1994. It is primarily based out of Durham, United States. As of Dec 2024, Pappas Capital is an active investor, having invested …See details»
Pappas Capital - BEAMSTART
Proven Leaders in Advancing Life Science. Investing in life science with the goal of improving the lives of patients, while delivering superior results to investors. Pappas Capital is a global venture capital and commercial development firm …See details»
Pappas Capital - teaserclub.com
Pappas Capital Pappas Capital is a venture capital firm founded in 1994, specializing in investments within the life sciences sector, including biotechnology, biopharmaceuticals, drug …See details»
Private Equity List | Pappas Capital
Profile Pappas Capital invests exclusively in the life science sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United …See details»
Peter Young - Pappas Capital
Peter joined Pappas Capital in 2012, serving initially as an Executive-in-Residence and then as a Senior Venture Partner until his passing in February 2025. Peter was an experienced life …See details»
Pappas Capital | Institution Profile | Private Equity International
Use Private Equity International's platform to access the latest news, analysis, insights and fund data for Pappas Capital, as well as key contact information.See details»
Pappas Capital - Private Equity Investments & Executives
See Pappas Capital's 78 investments, 18 executives, and complete investor profile. Founded in 1994, Pappas Capital operates three lines of business: Pappas Ventures, Specialized Fund …See details»
Pappas Capital investment portfolio | PitchBook
Founded in 1994, Pappas Capital is a venture capital investment firm based in Durham, North Carolina.See details»
Pappas Capital - Waveup
Pappas Capital is a prominent venture capital firm based in Durham, North Carolina, specializing in investing in next-generation life science, agriculture, and technology companies. …See details»
Pappas Capital - Contacts, Employees, Board Members, Advisors
About Pappas Capital has 8 current employee profiles, including Senior Associate, OperationsLisa Dreyer.Pappas Capital has 2 board members and advisors, including Lee …See details»
Canadian startups focus on local funding as U.S. relations strain
1 day ago Because American president Donald Trump froze the U.S. Agency for International Development’s spending, one of the humanitarian organization’s biggest contractors had to …See details»
Richard Staub - Pappas Capital
Richard joined Pappas Capital in 2022 as a Venture Partner and is currently the President of R&D Solutions at IQVIA. Supported by high-powered information and technology assets, the clinical …See details»
Eric Trump announces lawsuit against Capital One over alleged de ...
Mar 7, 2025 The Trump Organization is suing Capital One for de-banking its accounts in 2021, according to Eric Trump. The lawsuit was filed in Miami-Dade Circuit Court and claimed that …See details»